Besponsa (Inotuzumab Ozogamicin Vials) 1mg

Besponsa (inotuzumab ozogamicin) is an anti-cancer therapy delivered as 1mg vials for infusion. This targeted drug is used in hematologic oncology to treat certain blood cancers. Besponsa belongs to the class of antibody-drug conjugates. Always consult a healthcare professional for personalized guidance.

Strength

1mg

Manufacturer / TM Owner

Pfizer

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Besponsa (inotuzumab ozogamicin) is prescribed for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). It may also be used in patients who are not candidates for intensive chemotherapy. This medication targets CD22-positive cancer cells to help reduce disease progression. Besponsa is administered under medical supervision in a clinical setting.

Side Effects

Besponsa works by delivering a cytotoxic agent directly to cancer cells, which may help shrink tumors and slow disease spread. Patients may experience changes in blood cell counts during treatment. Infusion-related reactions such as fever or chills can occur. Regular monitoring is recommended to assess response and manage side effects.

Precautions & Warnings

Keep Besponsa vials refrigerated and protect from light until use. Handle with care to avoid accidental exposure; use gloves and dispose of materials properly. Inform your healthcare provider about any pre-existing liver or heart conditions before starting treatment. Pregnant or breastfeeding individuals should discuss risks with a doctor.

Avoid Interactions

Besponsa may interact with strong CYP3A4 inhibitors or inducers, which can affect drug levels in the body. Avoid grapefruit products while using Besponsa, as they may alter metabolism. Live vaccines should not be administered during therapy. Discuss all medications, including over-the-counter and supplements, with your healthcare team.

Frequently Asked Questions

Besponsa is used to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).

Besponsa is given as an intravenous infusion in a healthcare setting, typically over several treatment cycles.

Common effects include low blood cell counts, fever, chills, and infusion-related reactions.

No, Besponsa must be administered by a healthcare professional in a clinical environment.

Besponsa may harm an unborn baby; discuss risks with your doctor if you are pregnant or planning pregnancy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.